Novartis gets $487m for US cell culture flu vac plant
Novartis will receive a further $487m (€366m) from the US HHS for its cell-culture flu vaccine plant in Holly Springs, North Carolina.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs